Related Experiment Video
Updated: Feb 3, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
Published on: December 9, 2010
Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies
Caroline B Derrick1, Jan Ostermann2,3, Sharon B Weissman1
1Department of Medicine, School of Medicine, University of South Carolina, Columbia, South Carolina.
Abstract:
Study participants were asked about their interest in switching to novel drug delivery systems that reduce the dosing frequency of antiretroviral regimens. Across a diverse, treatment-experienced cohort, we describe greatest interest in switching to an oral regimen taken once weekly, followed by injections taken every other month and twice-annual implants.
More Related Videos
Related Concept Videos
Pressure Gauges
Switching of BJT
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
Design Example: Strain Gauge Bridge or Wheatstone Bridge
Gene Therapy
Group Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

